Bio-Rad Laboratories BIO
$ 328.12
0.67%
Quarterly report 2024-Q3
added 10-31-2024
Country |
USA |
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NYSESPB |
CEO |
Mr. Norman Schwartz |
Employees in the company |
8 000 |
Shares |
29.2 M |
Market Cap[1] |
$ 9.58 B |
EBITDA (LTM) |
$ 324 M |
P/E (LTM) |
-10.01 |
P/S (LTM) |
4.13 |
EPS (LTM) |
-35.78 |
Other stocks of industry "Medical devices"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.